TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1

被引:0
|
作者
Hooriyeh Shapourian
Mustafa Ghanadian
Nahid Eskandari
Abolfazl Shokouhi
Gülderen Yanikkaya Demirel
Alexandr V. Bazhin
Mazdak Ganjalikhani-Hakemi
机构
[1] Isfahan University of Medical Sciences,Department of Immunology, Faculty of Medicine
[2] Isfahan University of Medical Sciences,Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences
[3] Isfahan University of Medical Sciences,Department of Endocrine and metabolism research center
[4] Yeditepe University,Department of Immunology, Faculty of Medicine
[5] Ludwig Maximilians University of Munich,Department of General, Visceral and Transplant Surgery
[6] German Cancer Consortium (DKTK),Regenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA)
[7] Partner Site Munich,undefined
[8] Istanbul Medipol University,undefined
来源
BMC Cancer | / 24卷
关键词
Acute myeloid leukemia (AML); T cell immunoglobulin and mucin-domain containing-3 (TIM-3); Galectin-9 (Gal-9); Glutamine metabolism; Glutaminase (GLS); Glutamate dehydrogenase (GDH);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response
    Sehrawat, Sharvan
    Reddy, Pradeep B. J.
    Rajasagi, Naveen
    Suryawanshi, Amol
    Hirashima, Mitsuomi
    Rouse, Barry T.
    PLOS PATHOGENS, 2010, 6 (05) : 1 - 16
  • [22] Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis
    Jing Kang
    Zhi-Feng Wei
    Ming-Xian Li
    Jing-Hua Wang
    Journal of Biosciences, 2020, 45
  • [23] Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis
    Kang, Jing
    Wei, Zhi-Feng
    Li, Ming-Xian
    Wang, Jing-Hua
    JOURNAL OF BIOSCIENCES, 2020, 45 (01)
  • [24] Role of Tim-3/Galectin-9 Inhibitory Interaction in Viral-Induced Immunopathology: Shifting the Balance toward Regulators'
    Sehrawat, Sharvan
    Suryawanshi, Allnol
    Hirashima, Mitsuomi
    Rouse, Barry T.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 3191 - 3201
  • [25] Effect of the Use of Galectin-9 and Blockade of the TIM-3 Receptor in the Latent Cellular Reservoir of HIV-1
    Sanz, Marta
    Madrid-Elena, Nadia
    Serrano-Villar, Sergio
    Vallejo, Alejandro
    Gutierrez, Carolina
    Moreno, Santiago
    JOURNAL OF VIROLOGY, 2021, 95 (05)
  • [26] The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal–fetal interface in early pregnancy
    Yan-Hong Li
    Wen-Hui Zhou
    Yu Tao
    Song-Cun Wang
    Yun-Lan Jiang
    Di Zhang
    Hai-Lan Piao
    Qiang Fu
    Da-Jin Li
    Mei-Rong Du
    Cellular & Molecular Immunology, 2016, 13 : 73 - 81
  • [27] Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
    Gleason, Michelle K.
    Lenvik, Todd R.
    McCullar, Valarie
    Felices, Martin
    O'Brien, M. Shea
    Cooley, Sarah A.
    Verneris, Michael R.
    Cichocki, Frank
    Holman, Carol J.
    Panoskaltsis-Mortari, Angela
    Niki, Toshiro
    Hirashima, Mitsuomi
    Blazar, Bruce R.
    Miller, Jeffrey S.
    BLOOD, 2012, 119 (13) : 3064 - 3072
  • [28] Peripheral Blood TIM-3 Positive NK and CD8+T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy
    Meggyes, Matyas
    Miko, Eva
    Polgar, Beata
    Bogar, Barbara
    Farkas, Balint
    Illes, Zsolt
    Szereday, Laszlo
    PLOS ONE, 2014, 9 (03):
  • [29] SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer
    Zhang, Li
    Tian, Sijuan
    Zhao, Minyi
    Yang, Ting
    Quan, Shimin
    Yang, Qing
    Song, Lihua
    Yang, Xiaofeng
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [30] SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer
    Li Zhang
    Sijuan Tian
    Minyi Zhao
    Ting Yang
    Shimin Quan
    Qing Yang
    Lihua Song
    Xiaofeng Yang
    Cancer Cell International, 20